Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amylyx Pharmaceuticals, Inc. - Common Stock
(NQ:
AMLX
)
1.830
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amylyx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via
Benzinga
Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles
November 09, 2023
The company says patient discontinuations mounted in the quarter.
Via
Investor's Business Daily
Earnings Preview For Amylyx Pharma
November 08, 2023
Via
Benzinga
Expert Ratings for Amylyx Pharma
August 11, 2023
Via
Benzinga
A Preview Of Amylyx Pharma's Earnings
August 09, 2023
Via
Benzinga
Why Shares of Amylyx Pharmaceuticals Were Up Monday
July 24, 2023
The company got a bump from an analyst's upgrade.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 09, 2023
Via
Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2023
October 19, 2023
These three lesser-known biotech companies are profitable and growing revenue.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
Via
Benzinga
2 Incredible Growth Stocks Near 52-Week Lows to Buy Now
October 10, 2023
These two high-tech bio companies may be too cheap to ignore right now.
Via
The Motley Fool
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
August 28, 2023
Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.
Via
InvestorPlace
4 Analysts Have This to Say About Amylyx Pharma
July 24, 2023
Via
Benzinga
7 Analysts Have This to Say About Amylyx Pharma
May 31, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Amylyx Pharma
May 15, 2023
Via
Benzinga
Analyst Expectations for Amylyx Pharma's Future
May 15, 2023
Via
Benzinga
3 Biotech Stocks to Buy Before Drug Trials End
July 28, 2023
Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.
Via
InvestorPlace
Amylyx Stock Has A Good Entry Point, Says Bullish Goldman Sachs
July 24, 2023
Shares of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) jumped in early trading on Monday, after remaining broadly flat last week.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
July 24, 2023
Via
Benzinga
Amylyx Pharma Earnings Preview
May 10, 2023
Via
Benzinga
Analyst Ratings for Amylyx Pharma
March 31, 2023
Via
Benzinga
EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's Amyotrophic Lateral Sclerosis Treatment
June 23, 2023
The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a negative opinion regarding Amylyx Pharmaceuticals Inc's (NASDAQ: AMLX) conditional marketing authorization...
Via
Benzinga
Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?
June 13, 2023
Which of these red-hot biotech stocks is the better buy right now?
Via
The Motley Fool
How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run
June 01, 2023
Shares surged into and out of the company's R&D Day, which included a surprise.
Via
Investor's Business Daily
2 Supercharged Growth Stocks to Buy Right Now
May 14, 2023
These two biopharma stocks might be poised for a major breakout.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 12, 2023
Via
Benzinga
US Stock Futures Signal Strong Finish To Wobbly Week — But Analyst Still Sees Recession Risk On Horizon
May 12, 2023
Via
Benzinga
Amylyx Blows Past Sales Expectations, Reports Unexpected Profit — Shares Rocket
May 11, 2023
The company was expected to post another loss, but instead came in with a gain of 2 cents per share.
Via
Investor's Business Daily
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
Biotech is expected to be a hotbed of mergers and acquisitions this year.
Via
The Motley Fool
Amylyx Pharmaceuticals - An Emerging Leader In ALS
April 12, 2023
Amylyx has sold off from its earnings report on March 13th. What has been driving this move and what does it mean for the long term prospects of Amylyx?
Via
Talk Markets
7 Biotech Stocks to Buy for 100% Returns
April 09, 2023
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.